ALPMY - AI Eye Podcast 665: ACN ALPMY
Vancouver, Kelowna, Delta, BC - February 28, 2022 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:
https://www.investorideas.com/Audio/Podcasts/2022/022822-AI-Eye.mp3
AI Eye Podcast 665: Stocks discussed: (NYSE: ACN) (OTC: ALPMY)
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NYSE:ACN) (OTC:ALPMY)
Accenture ( NYSE:ACN ) has helped Astellas Pharma Inc. ( OTC:ALPMY ) to create a "cloud-based core IT platform that serves as the foundation for an advanced, data-driven management model for the company's global operations." Data collected by this platform is then combined with technologies, such as artificial intelligence, robotic process automation and analytics to streamline its enterprise processes. Motoki Fujita, vice president and head of Global Business Services at Astellas, explained:
"The new platform will accelerate our Global Business Service efforts to integrate operations on a global scale. This will create an environment that contributes to the business by optimizing selling and administrative expenses and creating an environment that allows employees to focus on high value-added work. We will leverage AI, RPA, and other digital technologies to thoroughly visualize and automate operations, and drive toward the goal of Intelligent Operation."
Veritone, Inc. ( NasdaqGM:VERI ) has announced the launch of its intelligent distributed energy resource management solution (iDERMS) to "enable utilities, Independent Power Producers (IPP's) and microgrid developers to accelerate the transition to clean energy, while still meeting their strategic, regulatory and environmental objectives." Sean McEvoy, senior vice president of Energy at Veritone, said:
"We are extremely excited to make this launch official. The energy industry is in desperate need of more advanced technologies to solve the challenges and opportunities the rapid growth of distributed energy resources (DERs) brings. AI is the answer. We worked hard to ensure our iDERMS solution is prime-time ready and look forward to sharing the success our customers are experiencing using this technology."
Global AI in Drug Discovery to Reach $2.01B by 2025
A report published by Market Research Future finds that the global AI in Drug Discovery market is projected to reach $2.01 billion USD by 2025, registering a compound annual growth rate (CAGR) of 40.8 percent in the forecast period 2019-2025. An excerpt from the report's description outlines the applicability of AI in the Drug Discovery space:
Artificial intelligence (AI) has captured the imagination and attention of medical industry professionals over the past couple of years as several companies, and large research hospitals have been working on perfecting these systems for clinical use. The first concrete examples of how AI (also called deep learning, machine learning, or artificial neural networks) will help clinicians are now being commercialized. These systems may offer a paradigm shift in clinician workflow to boost efficiency while improving care and patient throughput at the same time.
Sam Mowers, Investorideas.com
Read and hear other editions of the AI Eye
For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea's original branded content includes podcasts and columns: Crypto Corner , Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast .
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Visit the Podcast page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Contact Investorideas.com
800 665 0411